参考文献/References:
［1］ 张火俊， 杨继金， 田建明， 等． 巨块型肝癌介入治疗后引起的急性肾功能衰竭［J］． 临床放射学杂志， 2005， 24： 631- 633．
［2］ Lee YH, Hsu CY, Hsia CY, et al. Hepatocellular carcinoma in uremic patients: is there evidence for an increased risk of mortality?［J］. J Gastroenterol Hepatol. 2013, 28: 348- 356.
［3］ Okusaka T, Okada S, Nakanishi T, et al. Phase Ⅱ trial of intra- arterial chemotherapy using a novel lipophilic platinum derivative （SM- 11355） in patients with hepatocellular carcinoma［J］. Invest New Drugs, 2004, 22: 169- 176.
［4］ Imai N, Ikeda K, Seko Y, et al. Transcatheter arterial chemotherapy with miriplatin for hepatocellular carcinoma patients with chronic renal failure: report of three cases［J］. Gut Liver, 2013, 7: 246- 251.
［5］ 陈跃光， 吕宝经． 对比剂肾功能损害防治的研究进展［J］． 介入放射学杂志， 2006， 15： 382- 384．
［6］ Cho HS, Seo JW, Kang Y, et al. Incidence and risk factors for radiocontrast- induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembo lization［J］. Clin Exp Nephrol, 2011, 15: 714- 719.
［7］ Weisbord SD, Palevsky PM. Iodinated contrast media and the role of renal replacement therapy［J］. Adv Chronic Kidney Dis, 2011, 18: 199- 206.
［8］ Teneva BH. Pathogenesis and assessment of renal function in patients with liver cirrhosis［J］. Folia Med （Plovdiv）, 2012, 54: 5- 13.
［9］ Zhou C, Wang R, Ding Y, et al. Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma［J］. Int J Clin Exp Pathol, 2014, 7: 2579- 2586.
相似文献/References:
[1]杨柏帅,施裕新,袁 敏,等.TACE治疗既往有肝功能衰竭史肝癌患者七例[J].介入放射学杂志,2014,(09):805.
YANG Bo shuai,SHI Yu xin,YUAN Min,et al.TACE treatment for patients with inoperable hepatocellular carcinoma and hepatic failure history： initial experience in seven cases[J].journal interventional radiology,2014,(05):805.
[2]邢桃红,牛焕章,周媛媛,等. TACE联合索拉非尼治疗23例中晚期肝细胞肝癌的护理[J].介入放射学杂志,2014,(05):449.
XING Tao- hong,NIU Huan- zhang,ZHOU Yuan- yuan,et al. Nursing for patients with advanced hepatocellular carcinoma receiving transcatheter arterial chemoembolization combined with sorafenib： initial experience in 23 cases[J].journal interventional radiology,2014,(05):449.
[3]阿布都外力·吾布力卡斯穆,迪里木拉提·巴吾冬,任伟新. 巴塞罗那肝癌B期患者TACE治疗的预后及生存分析[J].介入放射学杂志,2014,(05):435.
ABUDUWAILI Obulikasimu,DILMURAT Bawudun,REN Wei- xin.. Transcatheter arterial chemoembolization for the treatment of Barcelona stage B hepatocellular carcinoma： analysis of the prognosis and survival[J].journal interventional radiology,2014,(05):435.
[4]王 龙,张 勇,王亚运,等.125I粒子联合经导管动脉化疗栓塞治疗肝细胞肝癌伴门静脉癌栓临床有效性与安全性meta 分析[J].介入放射学杂志,2018,27(05):419.
WANG Long,ZHANG Yong,WANG Yayun,et al.125I seed implantation combined with TACE for the treatment of HCC complicated by portal vein tumor thrombus： a meta- analysis of its clinical effectiveness and safety[J].journal interventional radiology,2018,27(05):419.
[5]许 贇,沈 强,王 能,等.微波消融治疗＞70岁早期肝细胞肝癌患者效果分析[J].介入放射学杂志,2016,(04):332.
XU Yun,SHEN Qiang,WANG Neng,et al.Effect analysis of microwave ablation therapy for early hepatocellular carcinoma in patients over 70 years old[J].journal interventional radiology,2016,(05):332.
[6]吴志远,丁晓毅,黄 蔚,等.门脉粒子支架联合载药微球栓塞治疗肝癌7例[J].介入放射学杂志,2017,(02):161.
WU Zhiyuan,DING Xiaoyi,HUANG Wei,et al.Portal 125I seed stent implantation combined with drug-loaded microsphere embolization for the treatment of HCC： initial results in 7 patients[J].journal interventional radiology,2017,(05):161.
[7]王 燕,王茂强,段 峰.索拉非尼治疗中晚期肝癌预后因素分析[J].介入放射学杂志,2017,(03):258.
WANG Yan,WANG Maoqiang,DUAN Feng.Prognostic factor analysis of moderate- advanced hepatocellular carcinoma treated with sorafenib [J].journal interventional radiology,2017,(05):258.
[8]余天柱,罗剑钧,颜志平.血管内近程放疗与序贯三维适形放疗治疗门静脉主干癌栓的疗效对比 [J].介入放射学杂志,2017,(09):787.
YU Tianzhu,LUO Jianjun,YAN Zhiping.Endovascular brachytherapy vs. sequential three- dimensional conformal radiotherapy for the treatment of main portal vein tumor thrombus： a comparative study[J].journal interventional radiology,2017,(05):787.
[9]贾中芝,顾晓诚,蒋国民.门静脉癌栓分型对肝细胞性肝癌治疗方法的选择及患者预后的影响 [J].介入放射学杂志,2017,(10):944.
JIA Zhongzhi,GU Xiaocheng,JIANG Guomin.The application of portal vein tumor thrombus classification in selecting therapeutic method for HCC patients and in estimating the prognosis[J].journal interventional radiology,2017,(05):944.
[10]刘璐璐,章浙伟,杨永波,等.CT灌注参数动脉增强分数值在评估肝癌TACE术后疗效中的初步研究 [J].介入放射学杂志,2017,(11):988.
LIU Lulu,ZHANG Zhewei,YANG Yongbo,et al.Application of quantitative arterial enhancement fraction of multiphase perfusion CT imaging in evaluating the curative effect of transcatheter arterial chemoembolization for hepatocellular carcinoma[J].journal interventional radiology,2017,(05):988.